Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 2/20 | 0.39 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.33 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.33 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | LIPE | Q05469 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29950853 | 0.81 | ALDH1A1 (0.38) | ENPP2ORAI1ORAI2ORAI3LIPG | |
| SCHEMBL24181642 | 0.80 | ENPP2 (0.31) | ENPP2 | |
| SCHEMBL6934720 | 0.78 | AOC3 (0.37) | CETPMAPT | |
| SCHEMBL29367623 | 0.75 | ENPP2 (0.43) | ENPP2ORAI1ORAI2ORAI3LIPG | |
| SCHEMBL24389 | 0.75 | ENPP2 (0.43) | ENPP2ORAI1ORAI2ORAI3LIPG | |
| SCHEMBL7189135 | 0.73 | ALDH1A1 (0.44) | CA4CA5ACA14CA5BCETP | |
| SCHEMBL7189127 | 0.70 | CETP (0.34) | CA4CA7CETP | |
| SCHEMBL7930508 | 0.70 | ACHE (0.43) | CA7 | |
| SCHEMBL1275601 | 0.70 | GABRA1 (0.42) | CA6MAPT | |
| SCHEMBL3786749 | 0.70 | SIRT1 (0.46) | ENPP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800786-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11545631-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-03 | — | — | US | disclosed |
| US-20210143332-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| CN-112786817-A | Organic electroluminescent device | 三星显示有限公司 | 2021-05-11 | — | — | CN | disclosed |
| CN-111349107-A | Organic electroluminescent device and polycyclic compound for organic electroluminescent device | 三星显示有限公司 | 2020-06-30 | — | — | CN | disclosed |
| US-20200203627-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2020-06-25 | — | — | US | disclosed |
| US-20080138635-A1 | Conjugated Organic Molecules for Molecular Electronic Devices | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11800786-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | ODC1, AOC2, EED | ENPP2 4412/4885ORAI1 265/4885ORAI2 35/4885 |
| US-20200203627-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | EED, OCIAD2, AOC1 | ENPP2 4256/4885ORAI1 2126/4885ORAI2 533/4885 |
| US-20210143332-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | ODC1, AOC2, EED | ENPP2 4412/4885ORAI1 265/4885ORAI2 35/4885 |
| US-11545631-B2 | Organic electroluminescence device and polycyclic compound for organic electroluminescence device | EED, OCIAD2, AOC1 | ENPP2 4256/4885ORAI1 2126/4885ORAI2 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.